Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Afr J Prim Health Care Fam Med ; 16(1): e1-e9, 2024 Jun 14.
Artigo em Inglês | MEDLINE | ID: mdl-38949438

RESUMO

BACKGROUND:  Antenatal care remains critical for identifying and managing complications contributing to maternal and infant mortality, yet attendance among women in South Africa persists as a challenge. AIM:  This study aimed to understand the challenges faced by women attending antenatal care in Soweto, Johannesburg, using the three-delay model. SETTING:  This study was conducted in Soweto, Johannesburg. METHODS:  An exploratory, descriptive and qualitative research design was used, and in-depth interviews were conducted with 10 pregnant women and four women who had recently given birth. RESULTS:  Findings indicate delays in seeking care due to factors such as pregnancy unawareness, waiting for visible signs, and fear of human immunodeficiency virus (HIV) testing. Challenges such as transportation difficulties, distance to clinics, and facility conditions further impeded the initiation of antenatal care. Late initiation often occurred to avoid long waits, inadequate facilities, language barriers and nurse mistreatment. CONCLUSION:  From this study, we learn that challenges such as unawareness of pregnancy, cultural notions of keeping pregnancy a secret, fear of HIV testing, long waiting lines, high cost of transportation fees, clinic demarcation, shortage of essential medicines, broken toilets and verbal abuse from nurses have delayed women from initiating antenatal care early in Soweto, Johannesburg.Contribution: Challenges of women with antenatal care attendance in South Africa must be addressed by implementing community-based health education interventions, institutionalising HIV psycho-social support services and improving quality of antenatal care services in public health facilities.


Assuntos
Aceitação pelo Paciente de Cuidados de Saúde , Cuidado Pré-Natal , Pesquisa Qualitativa , Humanos , África do Sul , Feminino , Gravidez , Cuidado Pré-Natal/estatística & dados numéricos , Adulto , Infecções por HIV , Acessibilidade aos Serviços de Saúde , Adulto Jovem , Conhecimentos, Atitudes e Prática em Saúde , Fatores de Tempo , Entrevistas como Assunto
2.
Vaccines (Basel) ; 11(5)2023 May 09.
Artigo em Inglês | MEDLINE | ID: mdl-37243064

RESUMO

In combatting COronaVIrus Disease 2019 (COVID-19), immunization is the most prominent strategy. However, vaccination hesitancy-meaning delays in accepting or denying inoculation regardless of availability-has been identified as an essential threat to global health. Attitudes and perceptions play a pivotal role in vaccine acceptability. Meanwhile, uptake in South Africa's rollout has been particularly disappointing among youths. For that reason, we explored attitudes and perceptions of COVID-19 in 380 youths in Soweto and Thembelihle, South Africa, between April and June 2022. A staggering hesitancy rate of 79.2 percent was recorded (301/380). We found negative attitudes and confounded perceptions of COVID-19 to be fueled by medical mistrust and misinformation, with online channels as the main sources of non- and counterfactual claims stemming mostly from unregulated social media popular with youths. Understanding its underpinnings-and enhancing means of curbing vaccine hesitancy-will be paramount in boosting uptake in South Africa's immunization program, particularly among youths.

3.
PLoS One ; 13(12): e0208698, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30557330

RESUMO

BACKGROUND: In 2010, the South African Government initiated a voluntary medical male circumcision (VMMC) program as a part of the country's HIV prevention strategy based on compelling evidence that VMMC reduces men's risk of becoming HIV infected by approximately 60%. A previous VMMC costing study at Government and PEPFAR-supported facilities noted that the lack of sufficient data from the private sector represented a gap in knowledge concerning the overall cost of scaling up VMMC services. This study, conducted in mid-2016, focused on surgical circumcision and aims to address this limitation. METHODS: VMMC service delivery cost data were collected at 13 private facilities in three provinces in South Africa: Gauteng, KwaZulu-Natal, and Mpumalanga. Unit costs were calculated using a bottom-up approach by cost components, and then disaggregated by facility type and urbanization level. VMMC demand creation, and higher-level management and program support costs were not collected. The unit cost of VMMC service delivery at private facilities in South Africa was calculated as a weighted average of the unit costs at the 13 facilities. KEY FINDINGS: At the average annual exchange rate of R10.83 = $1, the unit cost including training and cost of continuous quality improvement (CQI) to provide VMMC at private facilities was $137. The largest cost components were consumables (40%) and direct labor (35%). Eleven out of the 13 surveyed private sector facilities were fixed sites (with a unit cost of $142), while one was a fixed site with outreach services (with a unit cost of $156), and the last one provided services at a combination of fixed, outreach and mobile sites (with a unit cost per circumcision performed of $123). The unit cost was not substantially different based on the level of urbanization: $141, $129, and $143 at urban, peri-urban, and rural facilities, respectively. CONCLUSIONS: The private sector VMMC unit cost ($137) did not differ substantially from that at government and PEPFAR-supported facilities ($132 based on results from a similar study conducted in 2014 in South Africa at 33 sites across eight of the countries nine provinces). The two largest cost drivers, consumables and direct labor, were comparable across the two studies (75% in private facilities and 67% in public/PEPFAR-supported facilities). Results from this study provide VMMC unit cost data that had been missing and makes an important contribution to a better understanding of the costs of VMMC service delivery, enabling VMMC programs to make informed decisions regarding funding levels and scale-up strategies for VMMC in South Africa.


Assuntos
Circuncisão Masculina/economia , Atenção à Saúde/economia , Procedimentos Cirúrgicos Eletivos/economia , Análise Custo-Benefício , Infecções por HIV/economia , Infecções por HIV/prevenção & controle , Custos de Cuidados de Saúde , Humanos , Masculino , Setor Privado , Melhoria de Qualidade/economia , População Rural , África do Sul , População Urbana , Programas Voluntários
4.
MMWR Morb Mortal Wkly Rep ; 67(11): 337-339, 2018 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-29565839

RESUMO

Male circumcision reduces the risk for female-to-male human immunodeficiency virus (HIV) transmission by approximately 60% (1) and has become a key component of global HIV prevention programs in countries in Eastern and Southern Africa where HIV prevalence is high and circumcision coverage is low. Through September 2017, the President's Emergency Plan for AIDS Relief (PEPFAR) had supported 15.2 million voluntary medical male circumcisions (VMMCs) in 14 priority countries in Eastern and Southern Africa (2). Like any surgical intervention, VMMC carries a risk for complications or adverse events. Adverse events during circumcision of males aged ≥10 years occur in 0.5% to 8% of procedures, though the majority of adverse events are mild (3,4). To monitor safety and service quality, PEPFAR tracks and reports qualifying notifiable adverse events. Data reported from eight country VMMC programs during 2015-2016 revealed that bleeding resulting in hospitalization for ≥3 days was the most commonly reported qualifying adverse event. In several cases, the bleeding adverse event revealed a previously undiagnosed or undisclosed bleeding disorder. Bleeding adverse events in men with potential bleeding disorders are serious and can be fatal. Strategies to improve precircumcision screening and performance of circumcisions on clients at risk in settings where blood products are available are recommended to reduce the occurrence of these adverse events or mitigate their effects (5).


Assuntos
Circuncisão Masculina/efeitos adversos , Infecções por HIV/prevenção & controle , Doenças Hematológicas/epidemiologia , Hemorragia/epidemiologia , Programas Voluntários , Adolescente , Adulto , África Oriental/epidemiologia , África Austral/epidemiologia , Criança , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem
5.
Virology ; 402(1): 187-96, 2010 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-20392471

RESUMO

Griffithsin (GRFT), Cyanovirin-N (CV-N) and Scytovirin (SVN) are lectins that inhibit HIV-1 infection by binding to multiple mannose-rich glycans on the HIV-1 envelope glycoproteins (Env). Here we show that these lectins neutralize subtype C primary virus isolates in addition to Env-pseudotyped viruses obtained from plasma and cervical vaginal lavages. Among 15 subtype C pseudoviruses, the median IC(50) values were 0.4, 1.8 and 20.1nM for GRFT, CV-N and SVN, respectively, similar to what was found for subtype B and A. Analysis of Env sequences suggested that concomitant lack of glycans at positions 234 and 295 resulted in natural resistance to these compounds, which was confirmed by site-directed mutagenesis. Furthermore, the binding sites for these lectins overlapped that of the 2G12 monoclonal antibody epitope, which is generally absent on subtype C Env. This data support further research on these lectins as potential microbicides in the context of HIV-1 subtype C infection.


Assuntos
Proteínas de Algas/farmacologia , Antivirais/farmacologia , Proteínas de Bactérias/farmacologia , Proteínas de Transporte/farmacologia , Proteína gp120 do Envelope de HIV/metabolismo , Lectinas/farmacologia , Manose/metabolismo , Adulto , Sítios de Ligação , Feminino , Glicosilação , Humanos , Concentração Inibidora 50 , Proteínas de Membrana , Testes de Sensibilidade Microbiana , Testes de Neutralização , Lectinas de Plantas , Plasma/virologia , Ligação Proteica , Vagina/virologia , Adulto Jovem
6.
J Virol ; 82(4): 1860-9, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18057243

RESUMO

The early autologous neutralizing antibody response in human immunodeficiency virus type 1 (HIV-1) subtype C infections is often characterized by high titers, but the response is type specific with little to no cross-neutralizing activity. The specificities of these early neutralizing antibodies are not known; however, the type specificity suggests that they may target the variable regions of the envelope. Here, we show that cross-reactive anti-V3 antibodies developed within 3 to 12 weeks in six individuals but did not mediate autologous neutralization. Using a series of chimeric viruses, we found that antibodies directed at the V1V2, V4, and V5 regions contributed to autologous neutralization in some individuals, with V1V2 playing a more substantial role. However, these antibodies did not account for the total neutralizing capacity of these sera against the early autologous virus. Antibodies directed against the C3-V4 region were involved in autologous neutralization in all four sera studied. In two sera, transfer of the C3-V4 region rendered the chimera as sensitive to antibody neutralization as the parental virus. Although the C3 region, which contains the highly variable alpha2-helix was not a direct target in most cases, it contributed to the formation of neutralization epitopes as substitution of this region resulted in neutralization resistance. These data suggest that the C3 and V4 regions combine to form important structural motifs and that epitopes in this region are major targets of the early autologous neutralizing response in HIV-1 subtype C infection.


Assuntos
Síndrome da Imunodeficiência Adquirida/imunologia , Especificidade de Anticorpos , Anticorpos Anti-HIV/imunologia , Proteína gp120 do Envelope de HIV/imunologia , HIV-1/imunologia , Motivos de Aminoácidos , Sequência de Aminoácidos , Quimera/imunologia , Epitopos/genética , Epitopos/imunologia , Feminino , Proteína gp120 do Envelope de HIV/química , HIV-1/genética , Humanos , Dados de Sequência Molecular , Fragmentos de Peptídeos/imunologia , Análise de Sequência de Proteína
7.
Virology ; 368(1): 172-81, 2007 Nov 10.
Artigo em Inglês | MEDLINE | ID: mdl-17632196

RESUMO

This study aimed to characterize genetic features of HIV-1 subtype C envelope glycoproteins capable of eliciting cross-reactive neutralizing antibodies during natural infections. The gp160 sequences were determined for 36 HIV-1 subtype C isolates (donor viruses) from infected individuals residing in Malawi, Zimbabwe, Zambia and South Africa, whose sera displayed a range of cross-neutralizing activities against a panel of 5 subtype C and 5 subtype B viruses (panel viruses). Hierarchical clustering analysis of neutralization data of the panel viruses predicted phylogenetic relationships between subtype B and C panel viruses, suggesting some subtype-specific neutralization determinants. A similar comparison of subtype C donor viruses showed no significant correlation; however of three donor sequence pairs resolvable by phylogenetic analysis, two were also associated within the neutralization clustering dendrogram, suggesting that closely related viruses may elicit antibodies targeting common neutralization determinants. Significantly, viruses that had shorter V1-V4 loops induced antibodies that showed more neutralization breadth against the subtype C panel viruses (p=0.0135). This study indicates that that some structural features of envelope, such as shorter variable loops, may facilitate the elicitation of cross-reactive neutralizing antibodies in natural infections. Collectively these data provide some insights into design features of an envelope immunogen aimed at inducing neutralizing antibodies.


Assuntos
Anticorpos Antivirais/imunologia , Reações Cruzadas , Proteína gp160 do Envelope de HIV/genética , Proteína gp160 do Envelope de HIV/imunologia , HIV-1/genética , HIV-1/imunologia , Adulto , Anticorpos Antivirais/sangue , Análise por Conglomerados , Feminino , Proteína gp160 do Envelope de HIV/química , Infecções por HIV/imunologia , Infecções por HIV/virologia , HIV-1/isolamento & purificação , Humanos , Malaui , Masculino , Filogenia , RNA Viral/genética , Análise de Sequência de DNA , África do Sul , Zâmbia , Zimbábue
8.
AIDS Res Hum Retroviruses ; 23(2): 204-15, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17331028

RESUMO

The human immunodeficiency virus type 1 (HIV-1) negative factor, or Nef, has a variety of functions that are important in viral pathogenesis. Sequence analysis has identified nef mutations that are linked to the rate of disease progression in adults and children infected with HIV-1 subtype B. Here we have sequenced and analyzed HIV-1 subtype C nef sequences from 34 children with rapid (RP) or slow progressing (SP) disease and identified polymorphisms associated with disease stage including motifs involved in specific pathogenic functions. Unlike subtype B, insertions and deletions in the N-terminal variable region were observed exclusively in SP children (8 out of 25). Strong positive selection pressures were found in sites of known functional importance among SP sequences, whereas RP had strong negative selection across the gene. A lineage analysis of selection pressures indicated weaker pressure across the nef gene in SP sequences bearing a deletion in region 8-12, suggesting this deletion has functional importance in vivo. Together these results suggest a differential adaptation of certain Nef functions related to disease progression, some of which may be attributable to immune-imposed pressures. These data broadly reflect previous studies on subtype B, corroborate the decreased cytopathicity of SP viruses, but also highlight potential subtype differences that require further investigation.


Assuntos
Genes nef/genética , Infecções por HIV/genética , Infecções por HIV/virologia , HIV-1/genética , Polimorfismo Genético/genética , Criança , Pré-Escolar , Estudos de Coortes , Progressão da Doença , HIV-1/classificação , HIV-1/patogenicidade , Humanos , Lactente , Recém-Nascido , Dados de Sequência Molecular , Análise de Sequência de RNA
9.
J Med Virol ; 78(10): 1262-8, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16927278

RESUMO

V3 serotyping is a technique for determining HIV-1 genetic subtype based on the binding of antibodies from patient sera or plasma to synthetic V3 peptides derived from subtype consensus sequences. Variation in the performance of this assay has been attributed to V3 sequence heterogeneity, the degree of which varies with patient disease progression, virus co-receptor usage, and genetic subtype. This study assessed the performance of a competitive peptide enzyme immunoassay (cPEIA) in samples from HIV-1 subtype C infected patients with varying disease profiles, including those with syncytium (SI) and non-syncytium-inducing (NSI) viruses. Out of 90 sera tested, 94.4% reacted strongly against the subtype C peptide. There was no significant difference in assay sensitivity among samples from advanced AIDS patients in which humoral immune response may be lower, nor among SI viruses which carry changes in the V3 sequence. Four samples were found to be cross-reactive with other subtypes and one acutely infected patient sample was non-reactive due to low anti-gp120 antibody titers. A significantly higher number of samples showed secondary reactivity to subtype A, compared to other subtypes (P < 0.005). In conclusion, the assay was able to identify HIV-1 subtype C infection with a high level of sensitivity (94%) irrespective of the stage of disease and therefore provides a valuable resource for the large-scale epidemiological monitoring of the spread of HIV-1 subtypes in South Africa.


Assuntos
Proteína gp120 do Envelope de HIV , Infecções por HIV/virologia , HIV-1/classificação , Técnicas Imunoenzimáticas/métodos , Fragmentos de Peptídeos , Kit de Reagentes para Diagnóstico , Sorotipagem/métodos , Linhagem Celular Transformada , Estudos de Coortes , Reações Cruzadas , Progressão da Doença , Feminino , Variação Genética , Células Gigantes , Proteína gp120 do Envelope de HIV/genética , Infecções por HIV/diagnóstico , HIV-1/fisiologia , Humanos , Lactente , Dados de Sequência Molecular , Fragmentos de Peptídeos/genética , Sensibilidade e Especificidade , África do Sul
10.
AIDS Res Hum Retroviruses ; 22(5): 458-65, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16706624

RESUMO

The genotypes and biological phenotypes of HIV-1 isolates obtained from 40 perinatally infected children in South Africa were analyzed. This included 15 infants who had HIV-related symptoms, most of whom died within 2 years of birth (rapid progressors), and 25 children who survived between 4 and 9 years with varying signs of disease (slow progressors). Heteroduplex mobility assays and sequence analysis confirmed that within the env and gag regions, all isolates were HIV-1 subtype C. Viral isolates from 14 of the 15 rapid progressors used the CCR5 coreceptor, whereas 1 (02ZARP1) used both the CXCR4 and CCR5 coreceptors. Among the 25 slow progressors, 22 isolates used CCR5 only, 2 used CXCR4 only, and 1 used both CCR5 and CXCR4. Two of the slow-progressing children who harbored CXCR4-using viruses had AIDS. All four CXCR4-using viruses had genotypic changes in the V3 region previously shown to be associated with CXCR4 usage. This cross-sectional study shows that HIV-1 subtype C viruses from both rapid- and slow-progressing perinatally infected children used predominantly CCR5. Similar to adults, CXCR4 usage was uncommon among HIV-1 subtype C isolates from pediatric infections.


Assuntos
Genes env , Genes gag , Infecções por HIV/virologia , HIV-1/genética , RNA Viral/genética , Síndrome da Imunodeficiência Adquirida/mortalidade , Criança , Pré-Escolar , Estudos Transversais , Progressão da Doença , Feminino , Genótipo , HIV-1/classificação , HIV-1/isolamento & purificação , Humanos , Lactente , Masculino , Dados de Sequência Molecular , Fenótipo , Filogenia , Receptores CCR5/metabolismo , Receptores CXCR4/metabolismo , Análise de Sequência de DNA , Fatores de Tempo
11.
AIDS Res Hum Retroviruses ; 22(12): 1306-12, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17209775

RESUMO

Baseline HIV-1 resistance data are important for resistance monitoring purposes especially in regions initiating large-scale antiretroviral treatment programs. We examined 40 protease and 35 reverse transcriptase amino acid sequences of HIV-1 subtype C from drug inexperienced patients from rural settings in South Africa for resistance mutations. Samples were collected between 2001 and 2004 prior to the availability of antiretrovirals through public health institutions. Ninety-five percent of patients had no major mutations in the protease gene, although substitutions M46L (2.5%) and G73S (2.5%), which according to the Stanford Genotypic Resistance Interpretation Algorithm are considered major mutations, were detected. In addition, a high prevalence of minor mutations was observed in the protease, with at least three minor resistance-associated mutations in 37% of the isolates. An isoleucine insertion at codon 37 was detected in one sequence. Most of the RT sequences were wild-type, although V118I (8.5%) and Y318F (5.7%) associated with resistance to lamivudine and nevirapine, respectively, were observed. Our data suggest that major resistance mutations among the drug-inexperienced population in South Africa may be rare, and routine resistance testing before the initiation of therapy in this initial stage of the treatment program may not be necessary.


Assuntos
Farmacorresistência Viral/genética , Infecções por HIV/genética , Protease de HIV/genética , HIV-1/efeitos dos fármacos , DNA Polimerase Dirigida por RNA/genética , Sequência de Aminoácidos , Antirretrovirais/uso terapêutico , Análise Mutacional de DNA , HIV-1/genética , Humanos , Dados de Sequência Molecular , Alinhamento de Sequência , Análise de Sequência de Proteína , África do Sul
12.
AIDS Res Hum Retroviruses ; 21(1): 103-9, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15665650

RESUMO

HIV prevalence in the Limpopo Province has increased rapidly within the past 10 years, as in other parts of South Africa. Little is known about the genetic and biological properties of HIV circulating in this region including the baseline drug resistance profiles. We therefore collected blood samples from 42 HIV-1-infected patients residing in this region for analysis. All samples were shown to belong to HIV-1 subtype C by env and gag heteroduplex mobility assay (HMA). Viral isolates from 14 of these patients were shown to use the CCR5 coreceptor exclusively and had gp120 V3 loop sequences consistent with this phenotype. Sequence analysis of both protease and reverse transcriptase genes showed that none of 13 isolates harbored primary resistance mutations. These data suggest that HIV-1 subtype C is the predominant subtype circulating in the Limpopo Province, and that viral strains from this region are indistinguishable from those found in other parts of South Africa.


Assuntos
Produtos do Gene env/genética , Produtos do Gene gag/genética , Infecções por HIV/epidemiologia , HIV-1/classificação , Adulto , Sequência de Aminoácidos , Farmacorresistência Viral/genética , Feminino , Genótipo , Infecções por HIV/virologia , HIV-1/genética , Análise Heteroduplex , Humanos , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Filogenia , Prevalência , RNA Viral/análise , RNA Viral/isolamento & purificação , Análise de Sequência de DNA , África do Sul/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...